Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

30 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
An anti-CD6 antibody for the treatment of COVID-19 patients with cytokine-release syndrome: report of three cases.
Filgueira LM, Cervantes JB, Lovelle OA, Herrera C, Figueredo C, Caballero JA, Sánchez N, Berrio J, Lorenzo G, Cepeda M, Ramos M, Saavedra D, Añe-Kouri AL, Mazorra Z, Leon K, Crombet T, Caballero A. Filgueira LM, et al. Among authors: mazorra z. Immunotherapy. 2021 Mar;13(4):289-295. doi: 10.2217/imt-2020-0235. Epub 2021 Jan 5. Immunotherapy. 2021. PMID: 33397150 Free PMC article.
Use of a Humanized Anti-CD6 Monoclonal Antibody (Itolizumab) in Elderly Patients with Moderate COVID-19.
Díaz Y, Ramos-Suzarte M, Martín Y, Calderón NA, Santiago W, Viñet O, La O Y, Oyarzábal JPA, Pérez Y, Lorenzo G, Cepeda M, Saavedra D, Mazorra Z, Estevez D, Lorenzo-Luaces P, Valenzuela C, Caballero A, Leon K, Crombet T, Hidalgo CJ. Díaz Y, et al. Among authors: mazorra z. Gerontology. 2020;66(6):553-561. doi: 10.1159/000512210. Epub 2020 Oct 26. Gerontology. 2020. PMID: 33105142 Free PMC article. Clinical Trial.
An anti-CD6 monoclonal antibody (itolizumab) reduces circulating IL-6 in severe COVID-19 elderly patients.
Saavedra D, Añé-Kourí AL, Sánchez N, Filgueira LM, Betancourt J, Herrera C, Manso L, Chávez E, Caballero A, Hidalgo C, Lorenzo G, Cepeda M, Valenzuela C, Ramos M, León K, Mazorra Z, Crombet T. Saavedra D, et al. Among authors: mazorra z. Immun Ageing. 2020 Nov 14;17(1):34. doi: 10.1186/s12979-020-00207-8. Immun Ageing. 2020. PMID: 33292350 Free PMC article.
Treatment of COVID-19 patients with the anti-CD6 antibody itolizumab.
Caballero A, Filgueira LM, Betancourt J, Sánchez N, Hidalgo C, Ramírez A, Martinez A, Despaigne RE, Escalona A, Diaz H, Meriño E, Ortega LM, Castillo U, Ramos M, Saavedra D, García Y, Lorenzo G, Cepeda M, Arencibia M, Cabrera L, Domecq M, Estévez D, Valenzuela C, Lorenzo P, Sánchez L, Mazorra Z, León K, Crombet T. Caballero A, et al. Among authors: mazorra z. Clin Transl Immunology. 2020 Nov 25;9(11):e1218. doi: 10.1002/cti2.1218. eCollection 2020. Clin Transl Immunology. 2020. PMID: 33304584 Free PMC article.
Associations among cytokines, EGF and lymphocyte subpopulations in patients diagnosed with advanced lung cancer.
Suárez GM, Añé-Kourí AL, González A, Lorenzo-Luaces P, Neninger E, Salomón EE, Cordero L, Catalá M, Ledón N, Pereira K, Sánchez MG, García B, Crombet T, Mazorra Z, Saavedra D, Lage A. Suárez GM, et al. Among authors: mazorra z. Cancer Immunol Immunother. 2021 Jun;70(6):1735-1743. doi: 10.1007/s00262-020-02823-1. Epub 2021 Jan 2. Cancer Immunol Immunother. 2021. PMID: 33388995 Free PMC article.
Nimotuzumab: beyond the EGFR signaling cascade inhibition.
Mazorra Z, Chao L, Lavastida A, Sanchez B, Ramos M, Iznaga N, Crombet T. Mazorra Z, et al. Semin Oncol. 2018 Jan;45(1-2):18-26. doi: 10.1053/j.seminoncol.2018.04.008. Epub 2018 May 2. Semin Oncol. 2018. PMID: 30318080 Free article. Review.
Thymic Polypeptide Fraction Biomodulina T Decreases Exhausted and Terminally Differentiated EMRA T Cells in Advanced Lung Cancer Patients Treated With Platinum-Based Chemotherapy.
Suárez GM, Catalá M, Peña Y, Portela S, Añé-Kourí AL, González A, Lorenzo-Luaces P, Díaz M, Molina MLA, Pereira K, Hernández JC, Ramos R, Reyes MC, Ledón N, Mazorra Z, Crombet T, Lage A, Saavedra D. Suárez GM, et al. Among authors: mazorra z. Front Oncol. 2022 Jan 27;12:823287. doi: 10.3389/fonc.2022.823287. eCollection 2022. Front Oncol. 2022. PMID: 35155258 Free PMC article.
30 results